Intellectual Property

---

bioverà is built on a protected intellectual property foundation focused on upstream respiratory intelligence, continuous physiological sensing, and non-invasive intervention at the nasal pathway in real time. The core technology is covered by a U.S. utility patent application, U.S. Patent Application No. 19/422,340, with additional provisional filings that expand capabilities to include fatigue detection, alcohol-related impairment sensing, and multimodal physiological analysis. The intellectual property centers on sensing and responding at the nasal interface, where airflow, neurological signaling, and physiological control converge. This strategic positioning enables higher fidelity signal capture and earlier non-invasive intervention compared to wrist, finger, or external wearable approaches. The platform includes protection across multiple embodiments, such as integration into wearable devices, smart glasses, and respiratory systems, making it challenging to replicate through alternative form factors without infringing on core claims. biovèra’s approach combines real-time physiological sensing, adaptive response, and non-disruptive intervention within a cohesive system architecture, creating a defensible position across both hardware and system-level implementations. The technology is backed by functional prototypes and real-world testing, showcasing continuous airflow sensing, early detection of instability, and immediate non-invasive response. All intellectual property is owned by biovèra and is available for licensing, co-development, and strategic partnerships.